The New York attorney general filed an antitrust lawsuit claiming that a plan by Actavis to withdraw an Alzheimer's treatment from the market early would force patients to switch to a new extended release version—effectively insulating its profits from low-price generic challengers.

Topics:  new york   actavis   alzheimer   early   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News